This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARK P. SCHULTZ, M.D.

Arch Intern Med. 1931;48(6):1138-1155.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the treatment of patients with rheumatic fever during the past year in this hospital it has been found that amidopyrine is decidedly superior to other drugs heretofore employed, namely, sodium salicylate, acetylsalicylic acid, the ethyl ester of phenylcinchoninic acid, cinchophen and neocinchophen.¹ As an adequate summary of the properties of amidopyrine is not available elsewhere, a brief review of the literature concerning it is presented as a preliminary to an account of the observations presented in this paper on rheumatic fever.

REVIEW OF THE LITERATURE

Filehne,² in 1896 and in 1897, described the synthesis, the properties and a few preliminary therapeutic trials of an antipyretic and analgesic which he arbitrarily named "pyramidon," but which he designated more accurately as 4-di-methyl amino-antipyrine. Antipyrine, a condensation product of methyl-phenyl hydrazine and aceto-acetic ester, was first converted by Stolz,³ in 1893, into amidopyrine, or pyramidon, by substituting a di-methyl . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Hospital of the Rockefeller Institute for Medical Research.

Footnotes
Submitted for publication, April 16, 1931.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?